Scientists Grow World’s First 3D Heart Pacemaker Using Human Stem Cells

Chinese researchers in Shanghai have developed the world’s first laboratory-grown sinoatrial node, the heart’s natural pacemaker, using human stem cells. The breakthrough, published in *Cell Stem Cell*, creates a 3D organoid that replicates the sinoatrial node’s function, beating autonomously and sending electrical signals like a human heart. This discovery could reduce reliance on artificial pacemakers, which require battery replacements and carry infection risks. The sinoatrial node regulates heartbeat rhythm by sending electrical impulses to coordinate contractions in the heart’s chambers. When it malfunctions, patients often need implanted pacemakers, but these devices have limitations, including battery failures and complications. The Shanghai team’s bioengineered pacemaker responded to medications and nerve signals similarly to a real heart, enabling lab-based studies of inherited heart rhythm disorders. The research involved introducing genetic mutations linked to slow heartbeats into the organoid to test potential treatments. While still experimental, the findings suggest biological pacemakers could offer a more natural, long-term solution for patients with heart rhythm issues. Further testing is required before clinical use, but experts believe this advancement could revolutionize heart disease treatment. Stem cell science and regenerative medicine are driving progress in addressing severe conditions. If successful, biological pacemakers may provide a safer, more sustainable alternative to current artificial implants. The study highlights the potential of lab-grown tissues to improve medical care for heart disorders.